Dear All,
Two very significant developments happened recently,though long expected.Rosiglitazone(Avandia) has been cleared of its bad label and it's restrictions have been removed.The FDA committee did not find any evidence about the drug's cardiovascular(Heart) adverse effects.I am sure we shall have another old drug in our therapeutic arsenal.I felt from the beginning that,this molecule was the victim of some bad publicity or unproven trial results which were done in a haste.Any ways we shall be little cautious in future and keep in mind the likely adverse events following the introduction of antidiabetic medications.
Another news is the results of a study done at our University(Cardiff),which showed that, Sulfonylurea drugs such as Glibenclamide and others, when used as first line treatment in T2DM patients were associated with more mortality figures than Metformin use as first line drug.It needs to be confirmed with a long standing trial.But I feel,it is expected because of the mechanism of action of the former group of medications.Some of these drugs could impair the myocardial ischaemic preconditioning.Now what it does mean ? How it impacts a diabetes patient ?
Sulfonylurea drugs act via Potassium channels of the beta cells.They also do have this action on simillar channels of heart muscle cells.Just understand that,it is precisely because of this action that,Glibenclmide and other sulfonylureas have some critical effect when one person has ischaemic preponderance.Now studies have shown that,these drugs when used as first line drugs,they tend to increase the mortality rate when compared to other drugs.
I believe that,Metformin and Glitazones are better.GLP-1 analogs and DPP inhibitors like gliptins are yet to be widely available and cost effective.Sulfonylureas should be used along with Metformin as added agents when MF fail to bring down the BG levels.
There are lot of misconceptions and myths surrounding Insulin initiation and usage.Let me address these issues in my next post.
Wish you all a happy and prosperous new year 2014.
Two very significant developments happened recently,though long expected.Rosiglitazone(Avandia) has been cleared of its bad label and it's restrictions have been removed.The FDA committee did not find any evidence about the drug's cardiovascular(Heart) adverse effects.I am sure we shall have another old drug in our therapeutic arsenal.I felt from the beginning that,this molecule was the victim of some bad publicity or unproven trial results which were done in a haste.Any ways we shall be little cautious in future and keep in mind the likely adverse events following the introduction of antidiabetic medications.
Another news is the results of a study done at our University(Cardiff),which showed that, Sulfonylurea drugs such as Glibenclamide and others, when used as first line treatment in T2DM patients were associated with more mortality figures than Metformin use as first line drug.It needs to be confirmed with a long standing trial.But I feel,it is expected because of the mechanism of action of the former group of medications.Some of these drugs could impair the myocardial ischaemic preconditioning.Now what it does mean ? How it impacts a diabetes patient ?
Sulfonylurea drugs act via Potassium channels of the beta cells.They also do have this action on simillar channels of heart muscle cells.Just understand that,it is precisely because of this action that,Glibenclmide and other sulfonylureas have some critical effect when one person has ischaemic preponderance.Now studies have shown that,these drugs when used as first line drugs,they tend to increase the mortality rate when compared to other drugs.
I believe that,Metformin and Glitazones are better.GLP-1 analogs and DPP inhibitors like gliptins are yet to be widely available and cost effective.Sulfonylureas should be used along with Metformin as added agents when MF fail to bring down the BG levels.
There are lot of misconceptions and myths surrounding Insulin initiation and usage.Let me address these issues in my next post.
Wish you all a happy and prosperous new year 2014.